(Q38430399)
Statements
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial (English)
Jennifer G Robinson
Bettina S Nedergaard
William J Rogers
Jonathan Fialkow
Joel M Neutel
David Ramstad
Ransi Somaratne
Jason C Legg
Patric Nelson
Scott M Wasserman
Robert Weiss
LAPLACE-2 Investigators